Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Equity Ratio (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Equity Ratio readings, the most recent being 950.21 for Q1 2026.

  • On a quarterly basis, Equity Ratio fell 1054.13% to 950.21 in Q1 2026 year-over-year; TTM through Feb 2026 was 950.21, a 1054.13% decrease, with the full-year FY2025 number at 36.5, down 93.36% from a year prior.
  • Equity Ratio reached 950.21 in Q1 2026 per CBIH's latest filing, down from 61.6 in the prior quarter.
  • The five-year high for Equity Ratio was 8.27 in Q4 2023, with the low at 950.21 in Q1 2026.
  • A 4-year average of 118.46 and a median of 32.64 in 2024 define the central range for Equity Ratio.
  • Year-over-year, Equity Ratio plummeted 38.41% in 2024 and then crashed 1054.13% in 2026.
  • Year by year, Equity Ratio stood at 8.27 in 2023, then plummeted by 294.87% to 32.64 in 2024, then plummeted by 88.7% to 61.6 in 2025, then plummeted by 1442.64% to 950.21 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Equity Ratio are 950.21 (Q1 2026), 61.6 (Q4 2025), and 65.79 (Q3 2025).